Trials / Recruiting
RecruitingNCT07217795
Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building
Developing a Telehealth Intervention for Alcohol and Trauma Among LGBTQ+ People
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- University of Rhode Island · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a two-part study to develop and test a brief, virtual therapy program for lesbian, gay, bisexual, transgender, and queer (LGBTQ+) people who have experienced trauma and use alcohol. Phase 1: You'll be invited to share your perspective to help make the program relevant, inclusive, and affirming. Phase 2: You may have the opportunity to try the adapted program by receiving free virtual therapy with LGBTQ+-affirming therapists.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | CBT + expressive writing | This study will test a remotely delivered intervention combining Cognitive Behavioral Therapy (CBT) and Expressive Writing (EW) to address unhealthy alcohol use and traumatic stress among sexual minority women (SMW; e.g., lesbian, bisexual women) and transgender and gender-diverse (TGD) individuals. The intervention, called Recovery through Inhibitory Learning, Self-Efficacy Building, Problem-Solving, and Community Building (RISE), integrates CBT modules on assertiveness, problem-solving in high-risk situations, and building social connections with a brief EW program tailored to SMW and TGD participants. Four modules from the Unified Protocol (UP), a transdiagnostic CBT approach, will be adapted: (1) psychoeducation, goal setting, and motivational enhancement; (2) mindful emotional awareness; (3) cognitive flexibility; and (4) countering emotion-driven behaviors. |
| BEHAVIORAL | Wait-List Control | Participants assigned to the wait-list will not receive active treatment during the study period but will be offered the RISE intervention afterward. |
Timeline
- Start date
- 2025-11-30
- Primary completion
- 2026-11-01
- Completion
- 2028-09-01
- First posted
- 2025-10-16
- Last updated
- 2025-12-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07217795. Inclusion in this directory is not an endorsement.